Código QR

Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients

The potential of circulating tumor DNA (ctDNA) as a biomarker to assess the progression of various solid tumors has been explored extensively. In this study, we investigated the feasibility of utilizing a ctDNA sequencing panel specifically designed to target the most frequently mutated genomic regi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Mandy Radefeldt, Silke Stellmacher-Kaiser, Susann Krake, Brigitte Kragl, Sabrina Lemke, Christian Beetz, Peter Bauer, Christian Junghanß, Ruslan Al-Ali
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2023-11-01
Colecção:Life
Assuntos:
Acesso em linha:https://www.mdpi.com/2075-1729/13/12/2274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!